DHEA effects on myocardial Akt signaling modulation and oxidative stress changes in aged rats

Steroids

Volumn 74, Issue 13-14, 2009, Pages 1045-1050

  Jacob, Maria Helena Vianna Metello ^a   da Rocha Janner, Daiane ^a   Jahn, Matheus Parmegiani ^a   Kucharski, Luiz Carlos Rios ^a   Belló Klein, Adriane ^a   Ribeiro, Maria Flavia Marques ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Aging; Akt; DHEA; Heart; Oxidative stress

Indexed keywords

GLUTATHIONE TRANSFERASE; PRASTERONE; PROTEIN KINASE B; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ARTICLE; CARDIOMYOPATHY; CONTROL GROUP; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; EXPERIMENTAL RAT; LIPID PEROXIDATION; MALE; MODULATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; WISTAR RAT;

AGING; ANIMALS; DEHYDROEPIANDROSTERONE; GLUTATHIONE TRANSFERASE; HEART; LIPID PEROXIDATION; MALE; MYOCARDIUM; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE;

RATTUS; RATTUS NORVEGICUS;

EID: 70350570660     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2009.08.005     Document Type: Article

References (56)

1. Genazzani A.D., Lanzoni C., and Genazzani A.R. Might DHEA be considered a beneficial replacement therapy in the elderly?. Drugs Aging 24 3 (2007) 173-185
2. Bácsi K., Kósa J., Lazáry A., Horváth H., Balla B., Lakatos P., et al. Significance of dehydroepiandrosterone and dehydroepiandrosterone sulfate in different diseases. Orvosi Hetilap 148 14 (2007) 651-657
3. Wu S., Ruan Y., Yin M., and Lai W. Research on the age-related changes in the nitric oxide pathway in the arteries of rats and the intervention effect of dehydroepiandrosterone. Gerontology 53 4 (2007) 234-237
4. Barrett-Connor E., and Goodman-Gruen D. The epidemiology of DHEAS and cardiovascular disease. Annals of the New York Academy of Sciences 774 (1995) 259-270
5. Alexandersen P., Haarbo J., and Christiansen C. The relationship of natural androgens to coronary heart disease in males: a review. Atherosclerosis 125 (1996) 1-13
6. Rabijewski M., and Zgliczynski W. Positive effects of DHEA therapy on insulin resistance and lipids in men with angiographically verified coronary heart disease - preliminary study. Endokrynologia Polska 56 6 (2005) 904-910
7. Minamino T., and Komuro I. Vascular cell senescence; contribution to atherosclerosis. Circulation Research 100 1 (2007) 15-26
8. Picard J., Breton M., and Deudon E. The role of arterial wall proteoglycan in arteriosclerosis. La Semaine des Hôpitaux 55 (1979) 748-752
9. Nakamura T., Fox-Robichaud A., Kikkawa R., Kashiwagi A., Kojima H., Fujimiya M., et al. Transcription factors and age-related decline in apolipoprotein A-1 expression. Journal of Lipid Research 40 (1999) 1709-1718
10. Orentreich N., Brind J.L., Rizler L.R., and Vogelman J.H. Age-changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. The Journal of Clinical Endocrinology and Metabolism 59 (1984) 551-555
11. Migeon C.J., Keller A.R., Lawrence B., and Shepard T.H. Dehydroepiandrosterone and androsterone levels in human plasma: effect of age, sex, day-to-day and diurnal variation. The Journal of Clinical Endocrinology and Metabolism 17 (1957) 1051-1062
12. Arlt W. Dehydroepiandrosterone and ageing. Best Practice & Research Clinical Endocrinology & Metabolism 18 3 (2004) 363-380
13. Yildirim A., Gumus M., Dalga S., Sahin Y.N., and Akcay F. Dehydroepiandrosterone improves hepatic antioxidant systems after renal ischemia-reperfusion injury in rabbits. Annals of Clinical and Laboratory Science 33 4 (2003) 459-464
14. Yoshimura M. Cardiac aldosterone. Nippon Rinsho 64 5 (2006) 837-842
15. Pelissier M.A., Muller C., Hill M., and Morfin R. Protection against dextran sodium sulfate-induced colitis by dehydroepiandrosterone and 7alpha-hydroxy- dehydroepiandrosterone in the rat. Steroids 71 3 (2006) 240-248
16. Aksoy Y., Yapanoglu T., Aksou H., and Yildirim A.K. The effect of dehydroepiandrosterone on renal ischemia-reperfusion-induced oxidative stress in rabbits. Urological Research 32 3 (2004) 93-96
17. Gallo M., Aragno M., Gatto V., Tamagno E., Brignardello E., Manti R., et al. Protective effect of dehydroepiandrosterone against lipid peroxidation in a human liver cell line. European Journal of Endocrinology 141 (1999) 35-39
18. Korantzopoulos P., Galaris D., Papaioannides D., and Siogas K. The possible role of oxidative stress in heart failure and the potential of antioxidant intervention. Medical Service Monitor: International Medical Journal of Experimental and Clinical Research 9 6 (2003) RA140-RA145
19. Yung L.M., Leung F.P., Yao X., Chen Z.Y., and Huang Y. Reactive oxygen species in vascular wall. Cardiovascular & Hematological Disorders - Drug Targets 6 1 (2006) 1-19
20. Valko M., Leibfritz D., Moncol J., Cronin M.T.D., Mazur M., and Telser J. Free radicals and antioxidants in normal physiological functions and human disease. International Journal of Biochemistry & Cell Biology 39 (2007) 44-84
21. Dröge W. The plasma redox state and ageing. Ageing Research Reviews 1 2 (2002) 257-278
22. Tanaka T., Nakamura H., Yodoi J., and Bloom E.T. Redox regulation of the signaling pathways leading to eNOS phosphorylation. Free Radical Biology & Medicine 38 9 (2005) 1231-1242
23. Mullonkal C.J., and Toledo-Pereyra L.H. Akt in ischemia and reperfusion. Journal of Investigative Surgery 20 3 (2007) 195-203
24. DeBosch B., Treskov I., Lupu T.S., Weinheimer C., Kovacs A., Courtois M., et al. Akt1 is required for physiological cardiac growth. Circulation 113 17 (2006) 2097-2104
25. Jacobshagen C., Gruber M., Teucher N., Schimdt A.G., Unsold B.W., Toischer K., et al. Celecoxib modulates hypertrophic signaling and prevents load-induced cardiac dysfunction. European Journal of Heart Failure 10 4 (2008) 334-342
26. Legrain S., and Girard L. Pharmacology and therapeutic effects of dehydroepiandrosterone in older subjects. Drugs Aging 20 13 (2003) 949-967
27. Labrie F., Luu-The V., Martel C., Chernomoretz A., Calvo E., Morissette J., et al. Dehydroepiandrosterone (DHEA) is an anabolic steroid like dihydrotestosterone (DHT), the most potent natural androgen, and tetrahydrogestrinone (THG). Journal of Steroid Biochemistry & Molecular Biology 100 (2006) 52-58
28. Medina M.C., Souza L.C., Caperuto L.C., Anhê G.F., Amanso A.M., Teixeira V.P.A., et al. DHEA increases β-cell mass and improves the glucose-induced insulin secretion by pancreatic islets from aged rats. FEBS Letters 580 (2006) 285-290
29. Campbell C.S., Caperuto L.C., Hirata A.E., Araujo E.P., Velloso L.A., Saad M.J., et al. The phosphatidylinositol/Akt/atypical PKC pathway is involved in the improved insulin sensitivity by DHEA in muscle and liver of rats in vivo. Life Sciences 76 1 (2004) 57-70
30. Llesuy S.F., Milei J., Molina H., Boveris A., and Milei S. Comparison of lipid peroxidation and myocardial damage induced by adriamycin and 4′-epiadrimicynin mice. Tumori 71 (1985) 241-249
31. Gonzalez-Flecha B., Llesuy S.F., and Boveris A. Hydroperoxide-initiated chemiluminescence: an assay for oxidative stress in biopsies of heart, liver and muscle. Free Radical Biology & Medicine 10 (1991) 93-100
32. Marklund S.L. Pyrogallol autoxidation. In: Greenwald R.A. (Ed). Handbook of methods for oxygen radical research (1985), CRC Press, Boca Raton, Florida 243-247
33. Aebi H. Catalase in vitro. Methods in enzymology 105 (1984) 121-126
34. Mannervick B., and Gluthenberg C. Glutathione transferase (human placenta). Methods in Enzymology 77 (1981) 231-235
35. Laemmli V. Cleavage of structural proteins during the assembly of the head of bacteriophageT4. Nature 227 (1970) 680-685
36. Jacob M.H.V.M., Janner D.R., Belló-Klein A., Llesuy S.F., and Ribeiro M.F.M. Dehydroepiandrosterone modulates antioxidant enzymes and Akt signaling in healthy Wistar rat hearts. Journal of Steroid Biochemistry & Molecular Biology 112 1-3 (2008) 138-144
37. Laurine E., Lafitte D., Grégoire C., Sérée E., Loret E., Douillard S., et al. Specific binding of DHEA to the N terminus of the microtubule-associated protein MAP2. Journal of Biological Chemistry 278 32 (2003) 29979-29986
38. Lowry O.H., Rosebrough A.L., Farr A.L., and Randall R. Protein measurement with the folin phenol reagent. The Journal of Biological Chemistry 193 (1951) 265-275
39. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72 (1976) 248-254
40. Song G., Ouyang G., and Bao S. The activation of Akt/PKB signaling pathway and cell survival. Journal Cellular Molecular Medicine 1 (2005) 59-71
41. Sussman M. AKT"ing lessons for stem cells: regulation of cardiac myocyte and progenitor cell proliferation. Trends in Cardiovascular Medicine 17 7 (2007) 235-240
42. Liu D., Si H., Reynolds K.A., Zhen W., Jia Z., and Dillon J.S. Dehydroepiandrosterone protects vascular endothelial cells against apoptosis through a galphai protein-dependent activation of phosphatidylinositol 3-kinase-Akt and regulation of antiapoptotic Bcl-2 expression. Endocrinology 148 7 (2007) 3068-3076
43. Jiang Y., Miyazaki T., Honda A., Hirayama T., Yoshida S., Tanaka N., et al. Apoptosis and inhibition of the phosphatidylinositol 3-kinase/Akt signaling pathway in the anti-proliferative actions of dehydroepiandrosterone. Journal of Gastroenterology 40 5 (2005) 490-497
44. Paravicini T.M., and Touyz R.M. Redox signaling in hypertension. Cardiovascular Research 71 2 (2006) 247-258
45. Cai H., Li Z., Davis M.E., Kanner W., Harrison D.G., and Dudley S.C. Akt-dependent phosphorylation of serine 1179 and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase 1/2 cooperatively mediate activation of the endothelial nitric-oxide synthase by hydrogen peroxide. Molecular Pharmacology 63 (2003) 325-331
46. Araujo A., Schenkel P., Enzveiler A., Fernandes T., Partata W., Llesuy S., et al. The role of redox signaling in cardiac hypertrophy induced by experimental hyperthyroidism. Journal of Molecular Endocrinology 41 6 (2008) 423-430
47. Wu S., Li Q., Du M., Li S., and Ren J. Cardiac-specific overexpression of catalase prolongs lifespan and attenuates ageing-induced cardiomyocite contractile dysfunction and protein damage. Clinical and Experimental Pharmacology and Physiology 34 (2007) 81-87
48. Uchida K. 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Progress in Lipid Research 42 4 (2003) 318-343
49. Nakashima I., Liu W., Akhand A.A., Takeda K., Kawamoto Y., Kato M., et al. 4-Hydroxynonenal triggers multistep signal transduction cascades for suppression of cellular functions. Molecular Aspects of Medicine 24 4-5 (2003) 231-238
50. Guedes R.P., Araujo A.S.R., Janner D., Belló-Klein A., Ribeiro M.F., and Partata W.A. Increase in reactive oxygen species and activation of Akt signaling pathway in neuropatic pain. Cellular and Molecular Neurobiology 28 8 (2008) 1049-1056
51. Goldfarb A.H., McIntosh M.K., and Boyer B.T. Vitamin E attenuates myocardial oxidative stress induced by DHEA in rested and exercised rats. Journal of Applied Physiology 80 2 (1996) 486-490
52. Fukuda A., Nakamura Y., Ohigashi H., Osawa T., and Uchida K. Cellular response to the redox active lipid peroxidation products: induction of glutathione-S-transferase P by 4-hydroxy-2-nonenal. Biochemical and Biophysical Research Communications 236 (1997) 505-509
53. Halliwell B., and Gutteridge J.M.C. Free radicals in biology and medicine. 2nd ed (1989), Clarendon Press, Oxford
54. Singal P.K., Khaper N., Farahmand F., and Belló-Klein A. Oxidative stress in congestive heart failure. Current Cardiology Reports 2 (2000) 206-211
55. Candi F., and Verdetti J. Superoxide dismutase, glutathione peroxidase, catalase, and lipid peroxidation in the major organs of the aging rats. Free Radical Biology & Medicine 7 1 (1989) 59-63
56. Travacio M., and Llesuy S. Antioxidant enzymes and their modification under oxidative stress conditions. Ciência e Cultura 48 (1996) 9-13